Artikel/Veröffentlichungen mit TRIGA-S:

  • Potenziale der Liquid Biopsy am Beispiel der Onkologie. Der Artikel „Zulassung unter IVDR“ auf Seite 29 wurde von Dr. Andreas Franke und Dr. Stefanie Gaupp von TRIGA-S verfasst. Fokusheft BIO Deutschland (2022): >> Link
  • Diagnostik braucht Software: Wie sich ein Labordienstleister mittels Prozessmanagement weiterentwickelt. Horsch, M. (2022): >> Link
  • Survey Results: Status of IVDR Implementation 2022. Gemeinsame Veröffentlichung mit Climedo Health GmbH (2022): >> Link
  • IVDR-Konformität bis 2022: Wir bereiten Sie vor! Reil M, Hain J, BIO Deutschland Jahrbuch 2020/2021: >> Link
  • Leistungsbewertung von COVID-19-Diagnostika. Mutschelknaus L, transkript  (2_2020): >> Link

Wissenschaftliche Veröffentlichungen von Studien mit TRIGA-S-Beteiligung:

  • Multicenter performance evaluation of the Elecsys HCV Duo immunoassay. Majchrzak, M., Bronner, K., Laperchec, S., Riester, E., Bakker, E., Bollhagen, R., Klinkicht, M., Vermeulen, M., Schmidt, M. Journal of Clinical Virology (2022). Testing was conducted at TRIGA-S.
  • A multicenter performance evaluation of the new Elecsys Vitamin D total III assay versus reference isotope dilution liquid chromatography tandem mass spectrometry and commercially available comparators. Findeisen, P., Leis, M., Bendig, G., Grimme, J., Moser, E., Vogl, C., Christenson, R. Journal of Clinical Laboratory Analysis (2022). TRIGA-S was one of the study sites, and clinical research support was provided by Christine Chowanetz-Ernst, Head of Monitoring at TRIGA-S.
  • Intra- and inter-cycle variability of anti-Müllerian hormone (AMH) levels in healthy women during non-consecutive menstrual cycles: the BICYCLE study. Biniasch, M., Laubender, R.P., Hund, M., Buck, K., De Geyter, C. Clinical Chemistry and Laboratory Medicine (2021). Testing was conducted at TRIGA-S.
  • Multicenter Evaluation of a New, Fully Automated Androstenedione Electrochemiluminescence Immunoassay: Precision Analysis, Method Comparison, and Determination of Reference Ranges. Obermayer-Pietsch B, de Ramon M, Reichmuth C, Bendig G, Hutzler S, Taibon J, Rank CM, Findeisen P. The Journal of Applied Laboratory Medicine (2021). Further acknowledgements to Michaela Fink and Christine Chowanetz-Ernst for site management and monitoring activities.
  • Sensitivity of the Elecsys Anti-SARS-CoV-2 immunoassay as an aid in determining previous exposure to SARS-CoV-2. Kolja Hegel, J., Riester, E., Rank, E.M., Langen, F., Laengin, T., Findeisen, P. Infectious Diseases and Therapy (2021). Transport and storage of all study materials was performed by TRIGA-S.
  • Performance of an Automated Zika IgG Immunoassay in the Detection of Zika IgG Specific Antibodies – A Validation Approach in Samples from Prevalence Areas and Non-Endemic Countries. Laengin T, Augenstein S, Stadlbauer E, Girgnhuber H, Gloeck M, Riedel A. Trop. Med. Infect. Dis. (2020). Operator Dr. Stefanie Gaupp and study investigator Marta Leis, TRIGA-S.
  • Multicenter performance evaluation of the Elecsys® Insulin-like Growth FactorI immunoassay and establishment of reference ranges in a large cohort of healthy subjects. Kratzsch J, Anckaert E, Leis M, Kurka H, Kolm R, Findeisen P. 70th AACC Annual Scientific Meeting Abstracts (2018) A-214.
  • Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer. Holdenrieder S, Molina R, Qiu L, Zhi X, Rutz S, Engel C, Kasper-Sauer P, Dayyani F, M Korse C. Tumor Biology (2018) Vol: 40, Issue:4. Monitoring by Monika Steclik, TRIGA-S.
  • Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference. Grimsey P, Frey N, Bendig G, Zitzler J, Lorenz O, Kasapic D, Zaugg CE. Int J Pharmacokinet (2017) 2:247. Acknowledgements to Christine Chowanetz and Dr. Stefanie Gaupp, TRIGA-S.
  • An automated assay for growth differentiation factor 15. Wollert KC, Kempf T, Giannitsis E, Bertsch T, Braun SL, Maier H, Reim M, Christenson RH. J Appl Lab Med (2017) 5:510. Acknowledgements to Dr. Stefanie Gaupp, TRIGA-S.
  • Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Mueller C, Giannitsis E, Christ M, Ordoñez-Llanos J, McCord J, Body R, Panteghini M et al. Ann Emerg Med (2016) 68:76. Acknowledgements to Christine Chowanetz and Andrea Schatten, TRIGA-S.
  • Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M et al. N Engl J Med (2016) 1:13. Monitoring by Monika Sonner, TRIGA-S.